For the first time, we analyzed data gathered using CB Insights' machine learning algorithms to determine the best corporate venture capital firms from around the world.
For the past three years, we’ve partnered with The New York Times to compile a list of the Top 100 Venture Capital Partners from around the globe.
This year, we’ve also assembled a list of the world’s top 20 corporate venture capital (CVC) firms in response to the meteoric rise of CVC firms investing for the first time.
According to our recent Global CVC report, over 180 new corporate venture capital firms invested in 2017 — representing 66% growth over 2016.
In addition, the total amount of capital invested by all CVCs (both old and new) increased to record highs. In 2017, these firms invested over $31B in private market funding across 1791 disclosed equity deals.
Google Ventures was the most active corporate venture capital investor in 2017, followed by Intel Capital and Qualcomm Ventures in second and third place, respectively.
Among the top 20 CVCs are Asia-based investors Samsung Ventures, Bertelsmann Asia Investments, and Mitsui & Co. Global Investment.
Healthcare investors Novartis Venture Fund, Johnson & Johnson Innovation, SR One, Alexandria Venture Investments, Roche Venture Fund, Pfizer Venture Investments, and Novo Ventures are also featured.
Below is our comprehensive list of the Top 20 Corporate Venture Capital Firms. Scroll down for our Selection Methodology:
Our methodology for this inaugural CVC ranking is similar to that of our VC partner ranking. Below are the factors considered in ranking our list of top corporate venture capital firms:
- CVC Firm Exits – the frequency/volume, size, and stage of investment entry.
- Illiquid Portfolio Company Value – frequency, size, and stage of investment entry in high value — but un-exited — companies (given less weight due to illiquidity).
- Recency of Performance – focus on metrics since 2009. This is a ranking of today’s best CVCs — not the best CVCs in history.